FT  22 SEP 93 / UK Company News: Celltech forges link with Roche
Celltech Group, a Berkshire-based biotechnology company planning to seek a
listing in the next six months, has signed a manufacturing agreement with
Hoffmann-La Roche of the US, part of Roche, the Swiss pharmaceuticals
company.
Celltech's will make a monoclonal antibody in the UK for Roche's US
subsidiary and transfer technology to Roche for a second generation
manufacturing process.
In return it will receive revenues of about Pounds 30m over four years.
Roche is also planning to invest Pounds 5m in Celltech through the purchase
of convertible preference shares.
Mr Peter Fellner, Celltech's chief executive, said the investment and
contracts provided a valuable endorsement.
